Form 4: Kenvue CTO Granted 189,274 Restricted Stock Units

Kenvue's Chief Technology & Data Officer, Michael Wondrasch, was granted 189,274 Restricted Stock Units, vesting over three years.

Summary

• Michael Wondrasch, Kenvue Inc.'s Chief Technology & Data Officer, was granted 189,274 Restricted Stock Units (RSUs).
• The grant date for these RSUs was October 1, 2025.
• Each RSU corresponds one-for-one with Kenvue's common stock.
• The award vests in three equal installments on October 1, 2026, October 1, 2027, and October 1, 2028.
• Vesting is contingent upon Mr. Wondrasch's continued service through each vesting date.
• Following this transaction, Mr. Wondrasch beneficially owns 189,274 derivative securities (RSUs).

Sentiment

Score: 6

Explanation: Slightly positive as it aligns executive interests with shareholders and is a standard retention tool, indicating stability in executive compensation practices.

Positives

• Aligns the Chief Technology & Data Officer's interests with those of shareholders, as the value of the RSUs is tied to the company's stock performance.
• Serves as a retention mechanism, incentivizing continued service through the multi-year vesting schedule.
• Standard practice for executive compensation, indicating a structured approach to rewarding key personnel.

Negatives

• Potential for minor future share dilution upon vesting and conversion of RSUs into common stock.

Risks

• The reporting person risks forfeiture of unvested RSUs if their employment with Kenvue Inc. terminates before the scheduled vesting dates.

Future Outlook

The multi-year vesting schedule for the Restricted Stock Units indicates a long-term commitment from the Chief Technology & Data Officer to Kenvue Inc.'s performance and strategic objectives, aligning future incentives with shareholder value creation.

Industry Context

The grant of Restricted Stock Units to a key executive like the Chief Technology & Data Officer is a common and widely accepted practice in the consumer health and broader corporate sectors. It serves as a critical component of executive compensation packages, designed to attract, retain, and motivate top talent by linking their personal wealth directly to the company's long-term stock performance.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a significant component of executive compensation is a standard practice across major U.S. public companies, including peers in the consumer health sector such as Procter & Gamble (PG), Johnson & & Johnson (JNJ), and Colgate-Palmolive (CL).
• The three-year vesting schedule with equal annual installments is a typical structure for RSU grants, comparable to compensation plans observed at companies like Pfizer (PFE) or Unilever (UL), which aim to ensure executive retention and long-term alignment.
• The grant size of 189,274 units for a Chief Technology & Data Officer at a company of Kenvue's scale appears within the expected range for a senior executive, reflecting competitive compensation practices to secure leadership talent.

Stakeholder Impact

• Shareholders: Benefits from increased alignment of executive incentives with long-term stock performance.
• Employees: May signal stability in executive leadership and a commitment to competitive compensation practices.

Next Steps

• First RSU vesting installment on October 1, 2026.
• Second RSU vesting installment on October 1, 2027.
• Third RSU vesting installment on October 1, 2028.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of Restricted Stock Units to a key executive as part of their compensation package. Such grants are standard practice for executive retention and alignment of interests with shareholders. It does not present new information that would fundamentally alter the investment thesis for Kenvue Inc. or warrant a change in an existing investment recommendation.

Keywords

Kenvue, KVUE, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Michael Wondrasch, Chief Technology Officer, CTO, Stock Grant